Avandia Safety Announcement The Federal Drug Administration has issued Safety Communication concerning the ongoing review of the drug Avandia (rosiglitazone) as it relates to cardiovascular safety. Avandia is the brand name of an oral drug called rosiglitazone. Avandia is anti-diabetic drug in the thiazolidinedione class of drugs. The drug is (more…)
Read more
